Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23317)

• Formulation Name: Umeclidinium eq 62.5mcg base/inh powder
• Company: Glaxo Grp England

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Umeclidinium	(DM4E8O9)	Chronic obstructive pulmonary disease	CA22	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant